MALE Mamm Organoids
It is believed that the use of organoids derived from male breast tumors can be of fundamental support for the definition of the molecular mechanisms underlying the onset of the tumor. Furthermore, the development of such preclinical models could be of significant support for the identification of specific personalized and ad hoc therapeutic treatments for male pathology.
Conditions studied
Breast Neoplasms, Male
About this study
It is believed that the use of organoids derived from male breast tumors can be of fundamental support for the definition of the molecular mechanisms underlying the onset of the tumor. Furthermore, the development of such preclinical models could be of significant support for the identification of specific personalized and ad hoc therapeutic treatments for male pathology.
Primary outcomes
- Tumor tissue samples collected (36 months)
Eligibility information
Study locations
- IRCCS National Cancer Institute "Regina Elena", Rome, 00144 Italy
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-13.